Evidence map›Paper›PMID 39939996›Full record

ArticleBMC medicine2025

Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study.

Xue Zhang, Xin Dai, Aina Liu, Meili Sun, Lei Cong, Jing Liang, Zimin Liu, Zhen Li, Jinling Zhang, Jing Lv and 19 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Xue Zhang *Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Xin Dai *Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Aina Liu *Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
Meili SunDepartment of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Lei CongDepartment of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Jing LiangDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Zimin LiuDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhen LiDepartment of Oncology, Linyi Cancer Hospital, Linyi, China.
Jinling ZhangDepartment of Oncology, Linyi People's Hospital, Linyi, China.
Jing LvDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Fangli CaoDepartment of Medical Oncology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China.
Linli QuDepartment of Medical Oncology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China.
Haiyan LiuDepartment of Oncology, The Second Affiliated Hospital of Shandong First Medical University, Jinan, China.
Lu YueDepartment of Oncology, Qingdao Municipal Hospital, Qingdao, China.
Yi ZhaiDepartment of Oncology, Zibo Center Hospital, Zibo, China.
Fujun YangDepartment of Oncology, Weihai Municipal Hospital, Weihai, China.
Jiahui ChuDepartment of Pharmacy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Shuang WangDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Qian XuDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Jianyuan ZhouDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Shulun NieDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Miao HuangDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Ruitao XuDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Qiushi WangDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Xinyu SongDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Di ZhangDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Zhaodi NanDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Song LiDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China. songli@sdu.edu.cn.
Lian LiuDepartment of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China. lianliu@sdu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39939996
PMCPMC11817133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.